ALLMedicine™ Pediatric Nephrology Center

May 17th, 2021 - Lipoid proteinosis (LP) is a systemic, progressive, rare genodermatosis that manifests in early life with mucocutaneous lesions. Kidney involvement has not been described before, hence we aimed to investigate kidney findings in LP patients. In thi...

May 15th, 2021 - To evaluate the performance of 4 plasma protein markers for detecting disease activity in childhood-onset systemic lupus erythematosus (SLE) patients. Eighty-three consecutive pediatric patients fulfilling ≥4 ACR criteria for SLE and twenty-five h...

Apr 2nd, 2021 - The Pediatric Nephrology Workforce Crisis: A Call to Action.|2021|Ashoor I,Weidemann D,Elenberg E,Halbach S,Harshman L,|

Mar 31st, 2021 - Oral cyclophosphamide (CYP) is an important therapeutic agent in treatment of steroid-sensitive nephrotic syndrome having a steroid-dependent (SD) or frequent relapsing (FR) course. This retrospective observational study aimed to determine respons...

Mar 28th, 2021 - Steroids are the cornerstone of the treatment of childhood nephrotic syndrome. The optimal duration for the first episode remains a matter of debate. The aim of this study is to determine whether the 8 weeks International Study of Kidney Disease i...

Dec 17th, 2019 - Dietary management in pediatric chronic kidney disease (CKD) is an area fraught with uncertainties and wide variations in practice. Even in tertiary pediatric nephrology centers, expert dietetic input is often lacking. The Pediatric Renal Nutritio...

May 23rd, 2019 - These recommendations were systematically developed on behalf of the Network for Early Onset Cystic Kidney Disease (NEOCYST) by an international group of experts in autosomal dominant polycystic kidney disease (ADPKD) from paediatric and adult nep...

Dec 31st, 2018 - Kidney cysts can manifest as focal disease (simple and complex kidney cysts), affect a whole kidney (eg, multicystic dysplastic kidney or cystic dysplasia), or manifest as bilateral cystic disease (eg, autosomal recessive polycystic kidney disease.

Aug 12th, 2011 - The transfer of young patients from pediatric to adult renal care takes place after a transition process which involves both sides. It is important that it is individualized for each young person, focusing on self-management skills as well as asse...

May 17th, 2021 - Lipoid proteinosis (LP) is a systemic, progressive, rare genodermatosis that manifests in early life with mucocutaneous lesions. Kidney involvement has not been described before, hence we aimed to investigate kidney findings in LP patients. In thi...

May 15th, 2021 - To evaluate the performance of 4 plasma protein markers for detecting disease activity in childhood-onset systemic lupus erythematosus (SLE) patients. Eighty-three consecutive pediatric patients fulfilling ≥4 ACR criteria for SLE and twenty-five h...

Apr 2nd, 2021 - The Pediatric Nephrology Workforce Crisis: A Call to Action.|2021|Ashoor I,Weidemann D,Elenberg E,Halbach S,Harshman L,|

Mar 31st, 2021 - Oral cyclophosphamide (CYP) is an important therapeutic agent in treatment of steroid-sensitive nephrotic syndrome having a steroid-dependent (SD) or frequent relapsing (FR) course. This retrospective observational study aimed to determine respons...

Mar 28th, 2021 - Steroids are the cornerstone of the treatment of childhood nephrotic syndrome. The optimal duration for the first episode remains a matter of debate. The aim of this study is to determine whether the 8 weeks International Study of Kidney Disease i...

Mar 26th, 2020 - For patients with lupus nephritis, kidney response improves when voclosporin (Aurinia Pharmaceuticals) is added to mycophenolate and low-dose corticosteroids, results from the phase 3 AURORA trial show. The calcineurin inhibitor is the first novel...

Mar 26th, 2020 - For patients with lupus nephritis, kidney response improves when voclosporin (Aurinia Pharmaceuticals) is added to mycophenolate and low-dose corticosteroids, results from the phase 3 AURORA trial show. The calcineurin inhibitor is the first novel...

Dec 22nd, 2019 - A few months ago, I reviewed a Kidney International placebo-controlled trial of levamisole in children with steroid-dependent nephrotic syndrome.[1] Some of you may recall my overall enthusiasm for the trial. In brief, levamisole was effective at ...

Sep 17th, 2018 - CHICAGO – There’s another reason to worry about hypertension in children: cognitive decline later in life. In a pilot study, Marc Lande, MD, a professor of pediatric nephrology at the University of Rochester (N.

Jul 20th, 2018 - Evidence-based recommendations for appropriate nephrology testing in children are the latest installment of the American Board of Internal Medicine Foundation’s “Choosing Wisely” campaign. “Five things physicians and patients should question” were.